ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

House Committee Adds $73 Million To President’s NCI Budget, Only $13 Million Under Senate Figure

August 3, 1984

NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center.

December 7, 2001

DCT Board Okays Recompetitions

June 21, 1985

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

March 18, 1994

Sledge Elected ASCO President

January 16, 2009

Bass & Howes Bought By DDB Seattle

March 22, 2002